The paper introduces the basic concept of chirality
target specific selectivity and their relationship in radiopharmaceuticals. If the ligands labeled by radionuclides have chiral centers
the enantiomers must be separated
or the target specific selectivity will not be good. Chirality is one of the most important factors which must be considered in the study of the structure-activity relationship of radiopharmaceuticals.